Streetbeat News

Regulatory

FXI

China's Central Bank Monetary Policy Committee has committed to correcting pro-cyclical behavior and preventing the risk of exchange rate overshooting, according to Reuters.

Portfolio Pulse from Charles Gross

April 03, 2024 | 9:12 am

VGK

The Eurozone Consumer Price Index (CPI) for March showed a year-over-year increase of 2.4%, which is below the estimated 2.5% and the previous month's 2.6%.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 9:08 am

VGK

The Eurozone Consumer Price Index (CPI) for March showed a preliminary month-over-month increase of 0.8%, which is higher than the previous month's increase of 0.6%. This indicates a rise in inflation within the Eurozone, potentially impacting investment strategies and market sentiment.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 9:08 am

VGK

The Eurozone Core Consumer Price Index (CPI) for March showed a year-over-year increase of 2.9%, slightly below the estimated 3.0% and down from the previous 3.1%.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 9:07 am

X

U.S. Senator Sherrod Brown has urged the Biden administration to review Nippon Steel's potential acquisition of U.S. Steel Corp (NYSE:X) due to national security concerns related to Nippon Steel's ties with China. Nippon Steel refuted claims made in a Horizon Advisory report about its connections with the Chinese steel industry, stating its operations in China are minimal. The controversy could impact U.S.-Japan relations and the global commodity markets.

Portfolio Pulse from Benzinga Neuro

April 03, 2024 | 8:26 am

VNDA

Vanda Pharmaceuticals' Fanapt® has received U.S. FDA approval for the acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults. This approval marks a significant expansion of the Fanapt® franchise.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 6:58 am

BMY

The European Commission has expanded the approval of Bristol Myers Squibb's Reblozyl to include first-line treatment of transfusion-dependent anemia in adults with lower-risk myelodysplastic syndromes (LR-MDS). This approval is based on the Phase 3 COMMANDS study, where Reblozyl showed significant improvements in achieving transfusion independence and hemoglobin increase compared to epoetin alfa. This marks the fourth authorized indication in Europe for Reblozyl, highlighting its position as a first-in-class treatment for disease-related anemia and its superior efficacy over epoetin alfa in LR-MDS.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 6:31 am

AAPL

Apple Inc. is alleged to have blocked Jon Stewart from interviewing FTC Chair Lina Khan on his podcast amid antitrust investigations into Apple's business practices. This incident highlights the tension between tech giants and regulatory bodies, with Apple defending its business strategies against a lawsuit accusing it of monopolizing the smartphone market.

Portfolio Pulse from Benzinga Neuro

April 03, 2024 | 3:01 am

TSLA

Elon Musk's social media network X is experiencing a significant increase in pornographic content, causing user discomfort. A Bloomberg report links this surge to reduced content moderation under Musk's ownership. X is exploring monetization of adult content despite risks, including potential criminal activities. Concerns about protecting minors from explicit material have been raised, with reports of teenagers as young as 12 being exposed. The situation is exacerbated by the proliferation of porn spambots, posing challenges for user and advertiser retention.

Portfolio Pulse from Benzinga Neuro

April 03, 2024 | 1:56 am